|
End-of-day quote
Norwegian OTC
10/08/2026
|
5-day change | 1st Jan Change | ||
| 106.00 NOK | +4.95% |
|
-.--% | +253.33% |
| Market Cap | 165M 17.68M 15.78M 14.58M 13.21M 24.72M 1.68B 25.13M 175M 69.47M 879M 66.34M 64.93M 2.77B | P/E 2024 |
-0.75x | P/E 2025 | 0.52x |
|---|---|---|---|---|---|
| Enterprise Value | 160M 17.2M 15.36M 14.19M 12.86M 24.05M 1.63B 24.45M 171M 67.59M 855M 64.54M 63.16M 2.7B | EV / Sales 2024 |
0.09x | EV / Sales 2025 | 0.04x |
| Free-Float |
72.67% | Yield 2024 * |
-
| Yield 2025 | - |
| 04-28 | NHST : Quarterly report 2026 / Q1 | PU |
| 02-19 | NHST : Quarterly report 2025 / Q4 | PU |
| 17/10/25 | NHST : Quarterly report 2025 / Q3 | PU |
| 09/07/25 | NHST : Quarterly report 2025 / Q2 | PU |
| 23/05/25 | NHST : Annual report 2024 | PU |
| 1 day | +4.95% | ||
| 3 months | +4.95% | ||
| 6 months | +253.33% | ||
| Current year | +253.33% |
| Current year | 90 |  | 106 |
| 1 year | 90 | | 106 |
| 3 years | 29 | | 106 |
| 5 years | 29 | | 160.5 |
| 10 years | 29 | | 370 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ariane Grumstad
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julie Lundgren
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
Richard Olav Aa
BRD | Director/Board Member | 60 | 01/06/2024 |
Baard Haugen
BRD | Director/Board Member | 71 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.95% | -.--% | +253.33% | +112.00% | 17.68M | |
| -0.62% | +4.81% | -8.00% | +29.42% | 133B | |
| -1.55% | -0.33% | -1.50% | +58.19% | 83.36B | |
| -0.01% | +11.85% | -25.40% | +0.66% | 53.4B | |
| -0.74% | +8.18% | +13.52% | +26.14% | 44.02B | |
| +0.78% | +9.51% | -14.94% | +28.91% | 36.43B | |
| -2.55% | +13.09% | -22.00% | +7.46% | 21.34B | |
| +1.59% | +8.17% | -22.72% | -26.21% | 22.01B | |
| -1.53% | +4.67% | -21.10% | +6.03% | 20.69B | |
| -0.14% | +2.34% | +16.40% | +69.95% | 17.46B | |
| Average | +0.02% | +33.19% | +16.76% | +31.26% | 43.15B | |
| Weighted average by Cap. | -0.62% | +6.38% | -8.36% | +27.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.17B 126M 112M 104M 94.14M 176M 11.95B 179M 1.25B 495M 6.26B 473M 463M 19.75B | 1.2B 128M 114M 106M 95.83M 179M 12.17B 182M 1.27B 504M 6.38B 481M 471M 20.1B |
| Net income | -65.98M -7.07M -6.32M -5.83M -5.29M -9.89M -671M -10.06M -70.22M -27.8M -352M -26.54M -25.98M -1.11B | 89.98M 9.65M 8.61M 7.96M 7.21M 13.49M 916M 13.71M 95.75M 37.91M 480M 36.2M 35.43M 1.51B |
| Net Debt | 57.18M 6.13M 5.47M 5.06M 4.58M 8.57M 582M 8.72M 60.85M 24.09M 305M 23M 22.52M 961M | -4.48M -480K -429K -396K -359K -671K -45.56M -682K -4.76M -1.89M -23.87M -1.8M -1.76M -75.25M |
Employees
463
- Stock Market
- Stocks
- NHST Stock
Select your edition
All financial news and data tailored to specific country editions
